John Brennan, Professor and Director, Biointerfaces Institute, McMaster University tells us about some of the challenges of developing paper based diagnostic devices.
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Researchers provide evidence that mild traumatic brain injury is associated with greater neurodegeneration and reduced memory performance in people genetically at risk of Alzheimer's Disease.
In this podcast, we speak to Gustavo Stolovitsky to learn about his career and the work he is doing at IBM Research.
An interview with Dr. David Wong, Felix & Mildred Yip Professor and Director of the Center for Oral/Head & Neck Oncology Research at University of California Los Angeles.
Researchers at the Paul Scherrer Institute, Villigen and the ETH, Zurich, have combined to clarify the hydrogen spillover effect.
By joining forces, Sarah Cannon and Genospace will harness and use molecular profiling data to more effectively match cancer patients to cutting-edge therapies in clinical trials.
Collaboration is to focus on improving research and healthcare by improving the use and analysis of genomic data.
The consortium will bring together a number of clinical partners to help improve the diagnosis of infectious diseases and appropriate use of antibiotics.
Jan 23 - Jan 24, 2017
Jan 25 - Jan 26, 2017
Feb 01 - Feb 02, 2017